Volume 15, Number 12—December 2009
Dispatch
Respiratory Infection in Institutions during Early Stages of Pandemic (H1N1) 2009, Canada
Table 2
Etiologic agent | 2009 spring outbreaks, Ontario, no. (%) | 2009 spring outbreaks GTA,‡ no. (%) | 2008–2009 influenza season outbreaks, GTA,‡ no. (%) |
---|---|---|---|
Coronavirus OC43 | 1 (1) | 0 | 18 (23) |
Coronavirus NL63 | 0 | 0 | 6 (8) |
Coronavirus 229E | 4 (5) | 0 | 9 (12) |
Metapneumovirus | 17 (20) | 2 (12) | 21 (27) |
Respiratory syncytial virus A | 0 | 0 | 5 (6) |
Respiratory syncytial virus B | 1 (1) | 0 | 17 (22) |
Influenza A (H3, human) | 11 (13) | 6 (35) | 4 (5) |
Parainfluenza 1 | 1 (1) | 0 (0) | 1 (1) |
Parainfluenza 3 | 22 (27) | 7 (41) | 3 (4) |
Enterovirus/rhinovirus | 31 (37) | 3 (18) | 15§ (19) |
Pandemic (H1N1) 2009 virus | 1 (1) | 1 (6) | 0 |
Invalid test¶ | 0 | 0 | 1 (1) |
None | 6 (7) | 0 | 11 (14) |
Outbreaks tested | 83 | 17 | 78 |
*Luminex Molecular Diagnostics, Toronto, Ontario, Canada.
†GTA, Greater Toronto area. Spring season is delineated as April 20–June 12; influenza season is delineated as October 1–April 19.
‡Iincludes submissions by Peel, York, and Toronto Public Health Units only.
§Seven of the 15 outbreaks were confirmed as rhinovirus by the Seeplex RV12 detection kit (Seegene, Inc., Seoul, South Korea).
¶Reported when the internal control is not detected during a run.
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.